AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

X is significantly expanding its open source codebase, which includes the app’s “For You” algorithm and its core ranking engine, and adding a feature that will let users see if their account or posts ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

If you buy the new Pixel 11 Pro, you might have to proactively tell people that you bought the latest phone, unless they are following each and every launch. The main reason is that the Pixel 11 doesn ...

Find out why the results may temper claims that recursive self-improvement is on the horizon. —Michelle Kim This summer has been a scorcher for much of the Northern Hemisphere. June and July marked ...

The last time 96-year-old Audrey Staniland was assessed for in-home aged care funding was with a human clinician more than a decade ago. When her daughter applied for a reassessment late last year, ...

Artificial intelligence (AI) is poised to reshape pharmaceutical research by addressing some of the industry's most persistent challenges: lengthy timelines, high development costs and substantial ...

"Commencing Atlas suit initialisation system", crackles a synthesised female voice from out of my TV screen. "Life support systems activated", she continues. And eventually, "User initialisation ...

Section 1. Purpose. The United States Navy has experienced a series of shipbuilding setbacks stemming from overly complex designs and iterative design change procedures, which have resulted in cost ...

A great foldable with IP68 and a reliable triple camera, trapped in a shape everyone else seems to be moving on from. If you buy something from a Verge link, Vox Media may earn a commission. See our ...

Recursion Pharmaceuticals Inc. RXRX, Novavax Inc. NVAX and CRISPR Therapeutics AG CRSP are trending on Thursday. In pre-market trading, RXRX fell 1.42% to $3.45, CRSP dropped 0.15% to $59.72 and NVAX ...

Java Development Kit (JDK) 28, a non-LTS (Long-Term Support) or “feature release” of standard Java due in March 2027, has snagged its fifth proposed feature, the deprecation of the macOS/x64 port for ...